MF59-adjuvanted trivalent seasonal influenza vaccine compared to high-dose trivalent seasonal influenza vaccine among older adults, a systematic literature review

被引:0
|
作者
Dang, J. [1 ]
McGovern, I. [1 ]
Haag, M. [1 ]
Coleman, B. [2 ]
机构
[1] CSL Seqirus, Summit, NJ USA
[2] Univ Toronto, Publ Hlth, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
A81
引用
收藏
页码:S42 / S43
页数:2
相关论文
共 50 条
  • [11] Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults
    Athena P. Y. Li
    Carolyn A. Cohen
    Nancy H. L. Leung
    Vicky J. Fang
    Shivaprakash Gangappa
    Suryaprakash Sambhara
    Min Z. Levine
    A. Danielle Iuliano
    Ranawaka A. P. M. Perera
    Dennis K. M. Ip
    J. S. Malik Peiris
    Mark G. Thompson
    Benjamin J. Cowling
    Sophie A. Valkenburg
    npj Vaccines, 6
  • [12] Relative Effectiveness of the MF59-Adjuvanted Influenza Vaccine Versus High-Dose Influenza Vaccine in Older Adults With Influenza Risk Factors During the 2019-2020 US Influenza Season
    Imran, Mahrukh
    Mills, Carrie W.
    McDermott, Kimberly W.
    Dean, Alex
    Bogdanov, Alina
    McGovern, Ian
    Haag, Mendel D. M.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (08):
  • [13] Immunogenicity of aIIV3, MF59-adjuvanted seasonal trivalent influenza vaccine, in older adults ≥65 years of age: Meta-analysis of cumulative clinical experience
    Nicolay, Uwe
    Heijnen, Esther
    Nacci, Pantaleo
    Patriarca, Peter A.
    Leave, Brett
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 85 : S1 - S9
  • [14] Evaluating the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to High-Dose Trivalent and Other Egg-Based Influenza Vaccines among Older Adults in the US during the 2017-2018 Influenza Season
    Pelton, Stephen, I
    Divino, Victoria
    Shah, Drishti
    Mould-Quevedo, Joaquin
    DeKoven, Mitch
    Krishnarajah, Girishanthy
    Postma, Maarten J.
    VACCINES, 2020, 8 (03) : 1 - 17
  • [15] Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood
    Nakaya, Helder I.
    Clutterbuck, Elizabeth
    Kazmin, Dmitri
    Wang, Lili
    Cortese, Mario
    Bosinger, Steven E.
    Patel, Nirav B.
    Zak, Daniel E.
    Aderemg, Alan
    Dong, Tao
    Del Giudice, Giuseppe
    Rappuoli, Rino
    Cerundolo, Vincenzo
    Pollard, Andrew J.
    Pulendran, Bali
    Siegrist, Claire-Anne
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (07) : 1853 - 1858
  • [16] Assessing optimal use of the standard dose adjuvanted trivalent seasonal influenza vaccine in the elderly
    Thorrington, Dominic
    van Leeuwen, Edwin
    Ramsay, Mary
    Pebody, Richard
    Baguelin, Marc
    VACCINE, 2019, 37 (15) : 2051 - 2056
  • [17] Cross-protective potential of a MF59-adjuvanted quadrivalent influenza vaccine in older adults
    Isakova-Sivak, Irina
    Rudenko, Larisa
    LANCET INFECTIOUS DISEASES, 2021, 21 (07): : 900 - 901
  • [18] MF59™-adjuvanted seasonal influenza vaccine in young children
    Puig-Barbera, Joan
    Perez-Vilar, Silvia
    Diez-Domingo, Javier
    EXPERT REVIEW OF VACCINES, 2011, 10 (11) : 1519 - 1528
  • [19] Fluad - An Adjuvanted Seasonal Influenza Vaccine for Older Adults
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1486): : 8 - 8
  • [20] Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis
    Dell'Era, Laura
    Corona, Fabrizia
    Daleno, Cristina
    Scala, Alessia
    Principi, Nicola
    Esposito, Susanna
    VACCINE, 2012, 30 (05) : 936 - 940